Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

FOUND: 7 - You Need To See This

Protesters demand release of HIV funds ‘illegally’ withheld by Trump

People take to streets against Trump administration plans to rescind funding for life-saving international programs

The Guardian - US

Greg Louganis: Age, HIV Battle, How Much He Sold His Olympic Medals For and Why He's Quitting the US

Olympic legend Greg Louganis, 65, has sold his medals and LA home and is relocating to Panama, citing financial pressures, HIV care costs, and the search for a fresh start.

International Business Times UK

For many with HIV, drugs lifted their death sentence. Now they must face old age.

They survived HIV

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

HIV is on the rise among older Africans, but care and research overlook this group – lessons from Kenya and South Africa

For decades, public health efforts across sub-Saharan Africa have focused on HIV prevention, testing and treatment campaigns on children, and women of reproductive age, overlooking the population at older ages.

The Conversation

A Heavier Case Load, Diminished Care

Due to Trump’s funding cuts, “having sex is about to get a lot more dangerous,” warns a Los Angeles nurse whose work helps prevent the spread of HIV.

Capital & Main

Talking about sex isn’t always easy for teachers in South Africa. Here’s what they told us

Young people in rural Limpopo, the South African province bordering Botswana, Zimbabwe and Mozambique, face high risks of HIV, unplanned pregnancy, and other societal challenges.

The Conversation

Putin's 'Last Chance Army': HIV-Positive and Sick Civilians Lured With False Healthcare Promises to Fight in Ukraine

Russia is reportedly recruiting HIV-positive and sick civilians with false promises of healthcare in exchange for fighting in Ukraine. Critics have branded the campaign Putin's 'last chance army.'

International Business Times UK

Read news from The Economist, FT, and more,
with one subscription

‘My dad is a sick freak’: Woman’s father purposefully got HIV so daughter would look after him

The woman shared her very traumatic things her father had done with her viewers on TikTok.

We Got This Covered

Breakthrough study could lead to single-dose vaccine for HIV and Covid

The study treated mice with a vaccine that combined two different immunity stimulants

The Independent UK

EU approves new twice-yearly HIV prevention jab

The new treatment option comes amid a rise in HIV cases in parts of Europe.

Euronews

‘I was imprisoned for six months for being HIV-positive’

LIFE STORIES: Robert Suttle, an advocate for the rights of those living with HIV, was sentenced to jail after a former partner accused him of not disclosing his HIV-positive status before they had sex. He tells Ellie Muir about the outdated laws surrounding HIV that still exist in some US…

The Independent UK

Deadly infectious diseases on Australia's doorstep

Australia has been urged to help fight the deadly infectious diseases on its doorstep, including two major HIV outbreaks.

AAP

South Africa's most vulnerable struggle to find HIV medication after US aid cuts

Sex workers and transgender people are among South Africa's most vulnerable populations after the Trump administration slashed U.S. foreign aid and U.S.-funded health clinics dispensing HIV medication shut down

The Independent UK

This Overlooked Biotech Stock Is a Buy for Its Hidden Strengths

This biotech giant has hidden strengths that could unlock long-term upside.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Botswana was once ‘at risk of extinction’ from HIV. Now it is a world leader in eliminating the virus in children

The pioneering African country is lauded for slashing rates of mother-to-child transmission to just 1.2% and is holding trials that may now hold the key to curing young people

Benzinga

CVS Health Declines To Add Gilead's Steeply Priced New HIV Prevention Drug To Its Plans

CVS Health Inc. (NYSE:CVS) said it will not add Gilead Sciences Inc.’s (NASDAQ:GILD) new HIV prevention drug Yeztugo to its commercial plans.

The Conversation

Condoms, PrEP and vaccines: how the UK is expanding STI prevention

The UK has just introduced the world’s first national programme offering a vaccine to help protect against gonorrhoea. This coincides with increasing rates of sexually transmitted infections (STIs) including antibiotic-resistant strains of Neisseria gonorrhoeae, particularly among gay, bisexual and other men who have sex with men.

The Conversation

Friday essay: Trump and Kennedy are destroying global science. Even Einstein questioned facts – but there’s a method to it

Eight months into Donald Trump’s second presidency of the United States, truth and science are again under attack – with global consequences. USAID, which tackled HIV, TB, malaria and child malnutrition is gone. Funding has been withdrawn from GAVI, a public–private global alliance that helps buy vaccines for the world’s…

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

UK set to get first hospice dedicated to LGBTQ+ people with specialist HIV focus

A Hospice UK report released in 2023 found that end of life care received by trans and gender diverse people was usually not inclusive

LiveScience

Experimental HIV vaccines show promise in early safety test

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in both.

The Independent UK

A single injection for newborns could protect them against HIV for years, study suggests

Globally, an estimated 1.3 million women and girls living with HIV become pregnant every year, according to the World Health Organization

The Independent UK

RFK Jr. looks to boot panel that decides which HIV and cancer screenings will be free: report

Decisions from the U.S. Preventative Services Task Force impact millions of people’s access to preventative care for cancer, infectious diseases and mental health

Benzinga

Gilead's Newly Approved HIV Prevention Drug Poised To Add Billions To Future Sales

In June, the U.S. Food and Drug Administration (FDA) approved Gilead Sciences, Inc.'s (NASDAQ:GILD) Yeztugo (lenacapavir) as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV in adults and adolescents weighing at least 35kg, making it the first and only twice-yearly option available in the U.S. for people who need or…

The Independent UK

EU regulator approves injectable HIV drug that experts say could help stop transmission

The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV

Euronews

EU regulators greenlight twice-yearly HIV injection, hailed as medical breakthrough

The drug is expected to be formally approved by the European Commission this year.

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the European Commission

the World Health Organization

Health and Human Services

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.